Literature DB >> 8647863

ADP-ribosylation of the G protein Rho inhibits integrin regulation of tumor cell growth.

T Udagawa1, B W McIntyre.   

Abstract

Using a gastric derived tumor line, we investigated the involvement of beta 1 integrin and Rho in cell growth regulation in response to collagen. The addition of C3 exoenzyme from clostridium botulinum to specifically ribosylate and inhibit the function of the rho gene products inhibited cellular proliferation in a dose-dependent fashion. C3 exoenzyme exhibited broad cytostatic activity toward a number of tumor lines and induced G0/G1 accumulation, cyclin A inhibition, and pronounced alterations in cell morphology. Integrin-mediated adhesion to collagen led to the expression of the cyclin A gene whose expression could be blocked using anti-beta 1 integrin monoclonal antibodies. Phospholipid levels were induced upon beta 1 integrin-mediated adhesion to collagen, and the phospholipid induction was inhibited by either antibodies to beta 1 integrin or pretreatment of cells with C3 exoenzyme. Significant reduction in phospholipid levels correlated with proliferation for a panel of tumor lines deprived of adhesion to substrate. These results implicate a novel role for integrins and Rho in the regulation of tumour growth in response to matrix.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647863     DOI: 10.1074/jbc.271.21.12542

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Inactivation of Rho signaling pathway promotes CNS axon regeneration.

Authors:  M Lehmann; A Fournier; I Selles-Navarro; P Dergham; A Sebok; N Leclerc; G Tigyi; L McKerracher
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

2.  Infection of human endothelial cells with Bartonella bacilliformis is dependent on Rho and results in activation of Rho.

Authors:  A Verma; G E Davis; G M Ihler
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells.

Authors:  M Lerm; J Selzer; A Hoffmeyer; U R Rapp; K Aktories; G Schmidt
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

4.  Neuroprotective effects of C3 exoenzyme in excitotoxic retinopathy.

Authors:  Yun Wang; Ying Wang; Qiaona Yang; Liheng Guo; Yan Yin; Ning Fan; Xiaomin Zhou; Su-Ping Cai; Paul L Kaufman; Xuyang Liu
Journal:  Exp Eye Res       Date:  2014-06-11       Impact factor: 3.467

5.  The Rho family G proteins play a critical role in muscle differentiation.

Authors:  H Takano; I Komuro; T Oka; I Shiojima; Y Hiroi; T Mizuno; Y Yazaki
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Clostridium botulinum C2 toxin delays entry into mitosis and activation of p34cdc2 kinase and cdc25-C phosphatase in HeLa cells.

Authors:  H Barth; M Klingler; K Aktories; V Kinzel
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.

Authors:  D Gingras; S Lamy; R Béliveau
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

8.  Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.

Authors:  W Du; P F Lebowitz; G C Prendergast
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

9.  LFA-1 and kindlin-3 enable the collaborative transport of SLP-76 microclusters by myosin and dynein motors.

Authors:  Keith P Eidell; Alenka Lovy; Nicholas R Sylvain; Frank A Scangarello; Hayley I Muendlein; Michael J Ophir; Ken Nguyen; Maria-Cristina Seminario; Stephen C Bunnell
Journal:  J Cell Sci       Date:  2021-08-27       Impact factor: 5.235

10.  Adenosine diphosphate (ADP)-ribosylation of the guanosine triphosphatase (GTPase) rho in resting peripheral blood human T lymphocytes results in pseudopodial extension and the inhibition of T cell activation.

Authors:  D G Woodside; D K Wooten; B W McIntyre
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.